France
· Delayed Price · Currency is EUR Neolife Statistics
Total Valuation
Neolife has a market cap or net worth of EUR 7.36 million. The enterprise value is 7.78 million.
| Market Cap | 7.36M |
| Enterprise Value | 7.78M |
Important Dates
The next estimated earnings date is Tuesday, September 23, 2025.
| Earnings Date | Sep 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Neolife has 96.37 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 96.37M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +92.57% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.55 |
| PB Ratio | 1.71 |
| P/TBV Ratio | 3.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -14.87 |
| EV / Sales | 0.58 |
| EV / EBITDA | 52.22 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.60 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 9.85 |
| Debt / FCF | n/a |
| Interest Coverage | -19.94 |
Financial Efficiency
Return on equity (ROE) is -11.47% and return on invested capital (ROIC) is -5.24%.
| Return on Equity (ROE) | -11.47% |
| Return on Assets (ROA) | -4.21% |
| Return on Invested Capital (ROIC) | -5.24% |
| Return on Capital Employed (ROCE) | -10.44% |
| Revenue Per Employee | 610,506 |
| Profits Per Employee | -23,797 |
| Employee Count | 22 |
| Asset Turnover | 1.71 |
| Inventory Turnover | 10.43 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.33% in the last 52 weeks. The beta is 2.40, so Neolife's price volatility has been higher than the market average.
| Beta (5Y) | 2.40 |
| 52-Week Price Change | -5.33% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 58.70 |
| Average Volume (20 Days) | 73,328 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Neolife had revenue of EUR 13.43 million and -523,526 in losses. Loss per share was -0.01.
| Revenue | 13.43M |
| Gross Profit | 2.31M |
| Operating Income | -528,947 |
| Pretax Income | -630,781 |
| Net Income | -523,526 |
| EBITDA | 149,053 |
| EBIT | -528,947 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1.05 million in cash and 1.47 million in debt, giving a net cash position of -421,136 or -0.00 per share.
| Cash & Cash Equivalents | 1.05M |
| Total Debt | 1.47M |
| Net Cash | -421,136 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 4.30M |
| Book Value Per Share | 0.04 |
| Working Capital | 1.36M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 17.22%, with operating and profit margins of -3.94% and -3.90%.
| Gross Margin | 17.22% |
| Operating Margin | -3.94% |
| Pretax Margin | -4.70% |
| Profit Margin | -3.90% |
| EBITDA Margin | 1.11% |
| EBIT Margin | -3.94% |
| FCF Margin | n/a |
Dividends & Yields
Neolife does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -83.99% |
| Shareholder Yield | -83.99% |
| Earnings Yield | -7.11% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Neolife has an Altman Z-Score of 2.89. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.89 |
| Piotroski F-Score | n/a |